Le Lézard
Classified in: Health
Subject: AVO

Coalition Grows To Oppose Implementation of the CMS Clinical Labor Policy


WASHINGTON, Sept. 9, 2021 /PRNewswire-PRWeb/ -- Today, the United Specialists for Patient Access (USPA) is highlighting the overwhelming opposition to the CMS proposal to move forward with the clinical labor policy. The concerns over the clinical labor policy are consistent with the bipartisan Rush-Bilirakis letter circulating in the House. The letter currently has over 50 signatures from Democrats and Republicans across the political spectrum.

CLICK HERE to view the USPA coalition letter on the clinical labor issue.

The letter, addressed to Deputy Administrator and Director of the Center for Medicare Meena Seshamani, M.D., Ph.D., states, "the incorporation of new clinical labor data actually results in massive cuts of more than 15 to 20 percent to critical services in the PFS."

The letter to Dr. Seshamani continues, "The proposed rule includes troubling cuts of more than 20 percent to specialties under the PFS as a direct result of the so-called "budget neutrality" policy, the same policy which drove drastic cuts in the 2021 PFS Final Rule. Successive, cumulative cuts to specialists under the PFS are resulting in reimbursement ever more out of touch with actual resource needs as well as increased healthcare consolidation and healthcare costs, greater health inequities, and a healthcare system unable to meet the challenges of an ongoing pandemic."

List of organizations opposing Implementation of the CMS Clinical Labor Policy:

Alliance for Physical Therapy Quality and Innovation (APTQI)

Association of Black Cardiologists (ABC)

The Alliance of Wound Care Stakeholders

The American College of Cardiology (ACC)

The American College of Radiology (ACR)

American College of Radiation Oncology (ACRO)

The American College of Surgeons (ACS)

The American Rhinologic Society (ARS)

American Society of Diagnostic and Interventional Nephrology (ASDIN)

The American Society for Radiation Oncology (ASTRO)

The American Urological Association (AUA)

The American Vein and Lymphatic Society (AVLS)

The American Venous Forum (AVF)

CardioVascular Coalition (CVC)

Dialysis Vascular Access Coalition (DVAC)

The Fibroid Coalition

Outpatient Endovascular and Interventional Society (OEIS)

Preventive Cardiovascular Nurses Association (PCNA)

Society for Vascular Medicine (SVM)

United Specialists for Patient Access (USPA)

The Renal Physicians Association (RPA)

The Society for Cardiovascular Angiography and Interventions (SCAI)

The Society of Interventional Radiology (SIR)

The Society for Vascular Surgery (SVS)

###

About the United Specialists for Patient Access (USPA)
USPA is a coalition of practitioners and affiliated entities involved in providing office-based specialty care. Learn more at: http://www.uspaccess.org.

Media Contact

Grant Herring, United Specialists for Patient Access (USPA), +1 (202) 552-1708, [email protected]

 

 

SOURCE United Specialists for Patient Access (USPA)


These press releases may also interest you

at 09:01
The German group around EIS/Satisfyer/Triple A has purchased the entire product portfolio, patents, designs and brands as well as the inventory of FUN FACTORY as part of an asset deal effective on October 1st, 2024 and has already placed a reorder of...

at 09:00
Zhao Yan, Chairperson and CEO of Bloomage, attended the 15th Annual Meeting of the New Champions (Summer Davos Forum) organized by the World Economic Forum to offer insights on navigating the current uncertainties in the global economy. This year's...

at 07:32
Duchesnay Pharmaceutical Group (DPG), one of the eight companies across the country chosen to participate in the Government of Canada's Global Hypergrowth Project, is very proud to announce that it has been awarded the Parity Certificationtm by Women...

at 06:30
The global microscopy market is poised for significant growth, expected to reach USD 10.6 billion by 2029 from USD 8.1 billion in 2024, growing at a CAGR of 5.4%. Key drivers include rising cases of chronic diseases necessitating effective...

at 06:25
Genexine (KOSDAQ: 095700), a publicly-listed, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of serious unmet medical needs, announced a merger with EPD Biotherapeutics...

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...



News published on and distributed by: